General MedicationsINJECTIONGeneric

NORMIFLO

ARDEPARIN SODIUM

Standard Dose

5,000 UNITS/0.5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Max Dose

Refer to approved labeling

Primary Use

Marketing status: Discontinued

Summary

Approval overview NORMIFLO is listed in Drugs@FDA under application 020227 (NDA).

Marketing status: Discontinued Active ingredient ARDEPARIN SODIUM Form and strength INJECTABLE;INJECTION - 5,000 UNITS/0.5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor PHARMACIA AND UPJOHN Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview NORMIFLO is listed in Drugs@FDA under application 020227 (NDA). Marketing status: Discontinued Active ingredient ARDEPARIN SODIUM Form and strength INJECTABLE;INJECTION - 5,000 UNITS/0.5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor PHARMACIA AND UPJOHN Submission history See approval history documents.

Monitoring

• Marketing status: Discontinued

Interaction Notes

No interaction notes stored yet.